Tenax Therapeutics (TENX) Shares Outstanding (Diluted Average) (2010 - 2026)

Tenax Therapeutics' Shares Outstanding (Diluted Average) history runs 10 years deep, the most recent figure standing at $45.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 23.62% year-over-year to $45.2 million; the TTM figure through Mar 2026 stood at $45.2 million (up 23.62% YoY), while the FY2025 annual figure was $39.2 million, up 156.8% from the prior year.
• Shares Outstanding (Diluted Average) came in at $45.2 million for Q1 2026 at Tenax Therapeutics, up from $39.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $45.2 million in Q1 2026 to a low of $248447.0 in Q4 2023.
• A 4-year average of $22.5 million and a median of $25.9 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) soared 6046.87% in 2024 and rose 23.62% in 2026, its largest moves.
• Tenax Therapeutics' Shares Outstanding (Diluted Average) stood at $248447.0 in 2023, then jumped by 6046.87% to $15.3 million in 2024, then soared by 156.8% to $39.2 million in 2025, then advanced by 15.32% to $45.2 million in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $45.2 million, $39.2 million, and $39.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison